1-3 of 3
Michael J. Baltezor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 6405: Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting Notch signaling

Scott James Weir, Prasad Dandawate, Prabhu Ramamoorthy, Parthasarathy Ranjarajan, Robyn Wood, Amanda Brinker, Benjamin Woolbright, Mehmet Tanol, Tammy Ham, William McCulloch, Michael Dalton, Michael J. Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6405.
DOI: https://doi.org/10.1158/1538-7445.AM2020-6405
Published: 15 August 2020
View article
Journal Articles

Abstract 5882: Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer

Scott J. Weir, Partha Ranjarajan, Robyn Wood, Karl Schorno, Prabhu Ramamoorthy, Lian Rajweski, Kathy Heppert, Michael J. McKenna, William McCulloch, Greg A. Reed, Amanda Brinker, Michael J. Baltezor, Roy A. Jensen, John A. Taylor, Shrikant Anant
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5882.
DOI: https://doi.org/10.1158/1538-7445.AM2018-5882
Published: 01 July 2018
View article
Journal Articles

Abstract 1895: Ciclopirox prodrug for the prevention and therapy of non-muscle invasive bladder cancer

Parthasarathy Rangarajan, Satish Ramalingam, Dharmalingam Subramaniam, Michael J. Baltezor, Robyn Wood, Shrikant Anant, Scott Weir
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1895.
DOI: https://doi.org/10.1158/1538-7445.AM2015-1895
Published: 01 August 2015
View article